| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |